Markets
BSE See NSE See 39,046.34
85.55 (0.22%)
collapse Related Readings collapse

HSIL: Recommendation Review

| 5/3/2012 9:00 PM Thursday

We had recommended HSIL in DSIJ Vol. 27, Issue No. 4 (dated January 30–February 12, 2012). We had recommended the stock based on the company's dominant position in the sanitaryware market. We believe that HSIL is a clear beneficiary of the growth in the industry, which is at around 10-12 per cent per annum. The company is also undertaking a capacity expansion process, which will continue in FY13.

HSIL has two business verticals, viz. sanitaryware (47 per cent of revenues) and the container glass division (53 per cent of revenues). Its business is well diversified across all territories in India. The southern market contributes 30 per cent of its revenues, the north accounts for 25 per cent and 45 per cent comes from the rest of India. Higher volumes and better realisations have been key to the growth in both the divisions of this company. It has the biggest network of distributors and retailers in this industry, which is another factor that we considered while recommending the stock. Its brand, Hindware, enjoys a dominant market position with a 40 per cent market share, and adds 68 per cent to the total revenues of the company.

HSIL’s margins have been increasing over the last five years. It recorded an impressive growth of 21 per cent in the topline and 27 percent in the bottomline for 9MFY12. In the recently-concluded quarter, the company reported sales growth of 22 per cent, but its net profit saw a decline of six per cent mainly due to the rupee depreciation. Given that the rupee is still over the 52 per dollar mark, we see the company’s profitability taking some more beating going forward. With this rationale, we believe that investors should take this opportunity to book profits in the counter at its CMP of Rs 166, which gives an impressive 25 per cent capital appreciation from the recommended price of Rs 133.

HSIL Scrip movement

 

Find More Articles on: DSIJ Magazine, Reviews, Stock Recommendations, Fundamental Picks, Product, Mid Cap, Large Cap

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ Mindshare

MIDHANI and HAL partner to develop bio implants

Geyatee Deshpande / Article rating: 5.0

Mishra Dhatu Nigam Limited (MIDHANI) signs an MoU with Hindustan Antibiotics Limited (HAL). This MoU will provide synergy for quality manufacturing of MIDHANI’s Bio-medical Implants and get access to the pan-India distribution of HAL. This partnership is aimed to gain advantage from the strengths of both the companies and benefit users of Bio-medical products in India.

12345678910Last

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Logistics sector will play a vital role in making the concept of ‘Make in India’ a success. This will be further aided by some of the recent steps taken by Government of India such as granting of infra sector status to logistics sector.

Best and worst Performing Sector Funds of Year 2017

Best and worst Performing Sector Funds of Year 2017

As the year-end has approached most of you are eager to know the mutual fund movers and shakers of the year 2017. Read on to find the performance of various sector dedicated funds.

Markets may start positive, but volatility likely due to F&O expiry

Markets may start positive, but volatility likely due to F&O expiry

The start of the F&O expiry day is likely to be in the green, but volatility may creep in with the progress of the session. The SGX Nifty suggests that the Nifty could open at 10,525 with gains of 32 points at the opening bell. 

Pidilite announces buyback of Rs 500 crore

Pidilite announces buyback of Rs 500 crore

The buyback offer comprises purchase of up to 50,00,000 equity shares. The buyback offer size comprises 0.975 per cent of the total paid-up equity capital of the company.

Bank Nifty drags markets to close in the red

Bank Nifty drags markets to close in the red

The late session fall in Bank Nifty changed the direction of the market, leading to a marginal fall in the benchmark indices. Bank Nifty yet again resisted at its multiple point downward sloping trendline level at 25733.

Six major underperforming MF schemes having higher expense ratios

Six major underperforming MF schemes having higher expense ratios

Mutual funds with a large size of assets under management (AUMs) are supposed to have lower expense ratios. However, there are schemes with large AUMs but having higher expense ratios and generating lower returns. 

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma index has come in as the healer in an otherwise sluggish market. Index has given a consolidation breakout at the 9420 level today and if the it sustains 9420, followed by 9628 on the upside, it has a long way to go.

Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Following stocks are close to their 52-week low as at 12.35 p.m. on December 27.

Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The markets on December 27 opened gap down. BSE Sensex is trading at 34,068.15, up by 57.54 points and the Nifty is trading at 10,539.45, up by 7.95 points.

Five stocks with selling interest

Five stocks with selling interest

Overall volumes in futures & options currently stand at 62.75 lakh contracts with a turnover of Rs. 5,19,204.72 crore.